Healthcare
CBPE scores 22x return on IDIS sale
CBPE has sold IDIS to Clinigen for £225m, generating a 22x return
Foresight backs £2.6m MBO of Specac
Foresight introduces Kevin O'Donovan as company's new chair
Industrifonden in $14m round for Bonesupport
Round was led by unnamed Scandinavian pension fund
Vesalius Biocapital leads €6.2m Omeicos series-A
High-Tech Gründerfonds, IBB and KfW Bank also take part
Ardian-backed Anios acquires Deren
Deal marks first foreign acquisition by Anios since 2013 MBO
MVM leads €10m round for Onbone
Funding round brings new CEO on board
Amadeus leads £2.2m round for Congenica
Cambridge biotech has raised £5m, including government grants
Vivo and OrbiMed lead $120m series-B for Nabriva Therapeutics
US investors lead rounds with initial $50m tranche
HTGF backs Sonormed
Medtech company treats tinnitus with Tinnitracks therapy
Wise acquires NTC to build up Italian pharma group
GP to merge pharmaceutical business with PH&T
HBM Partners backs APR
Swiss firm holds 56% stake alongside Bright Technology Fund
Apposite scores 3.5x on By the Bridge sale
Apposite acquired the company in 2006
Sofinnova's Cerenis in €226m IPO
French biotech company raises €53.4m as part of listing
JPIF holds first close for maiden CEE-focused fund on $42m
Vehicle to target Poland-focused life sciences businesses
Forbion et al. back Rigontec’s €4.8m series-A
Total invested in round comes to €14.25m
Seventure holds second close for biotech fund on €100m
Health for Life Capital expected to reach €120m target
Vaaka Partners builds Fysios platform
New physiotherapy chain incorporates seven businesses
Ace and Auriga in €2.6m round for Pherecydes Pharma
Business angels also take part in round
Arx acquires DCB
Deal marks GP's second healthcare acquisition
VC-backed Canbex sold to Ipsen
Ipsen pays €6m upfront with further €90m expected
Cabot Square reaps 2x on Signature exit
Care home provider acquired by management
ProA Capital sells Clinica Eugin to NMC Health for €143m
Sale of Spanish business generates windfall for first buyout fund
Siparex et al. invest €1m in Calixar
Biotech company's existing investors all took part in round
FSN exits Teres
Surgical group sold to Wallenberg-owned medical group Aleris